Victoza (liraglutide) injection is a once-daily medication in the glucagon-like peptide-1 receptor agonist class of drugs. It is used in adults and children 10 years of age and older with type 2 diabetes, along with diet and exercise, to improve glucose management. It is also used to reduce the risk of major cardiovascular events such as heart attack, stroke, or death in adults with type 2 diabetes and known heart disease. It helps to release insulin and lowers the amount of glucose produced by the liver when glucose rises at mealtime. It also slows the absorption of mealtime blood glucose.
GLP-1 receptor agonists